semaglutide patent expiry europe Ozempic just got much, much cheaper in India. On March 21, Danish company Novo Nordisk's on semaglutide, the active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in What is the patent landscape

Diarrhea from semaglutide typically occurs during the initial weeks of treatment or when doses are increased, and most cases diminish over time as the body adapts to the medication

There is boxed warning on the GLP-1 agonists

Yes, you can have heart palpitations for no apparent reason

As a novel GLP-1 receptor agonist, semaglutide plays a pivotal role in managing type 2 diabetes by improving glycemic control and promoting weight loss

: GLP-1

These classifications are widely utilized in clinical and research settings to assess obesity-related health risks and guide medical interventions [5]